EUVIMEDEUVIMED entdecken
Studienprotokoll

How I do it: An institutional protocol for the management of RhD negative women who receive RhD positive blood

Rahaf Alkhateb, Kirea Mazzolini iD, Vipulkumar Pravinbhai Prajapati, Chantal Harrison, Kayla E Ireland, Donald Jenkins, John Daniels, Leslie Greebon

Transfusion · 2025

DOI: 10.1111/trf.18181 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Transfusion, 2025. Verfasst von Rahaf Alkhateb und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, UT Health San Antonio, San Antonio, Texas, USA. Hauptthemen laut MEDLINE: Rh-Hr Blood-Group System, Rho(D) Immune Globulin, Rh Isoimmunization, Blood Transfusion. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

RhD alloimmunization can result from blood transfusion or fetomaternal hemorrhage (FMH). Preventing alloimmunization in childbearing‐age women with FMH via utilization of RhD immunoglobulin (RhIG) is well known; however, there are no established protocols for RhD‐mismatched transfusions in emergent or traumatic settings. Here, we describe our hospital protocol for managing RhD negative women who receive RhD positive transfusions.

Design

Pathology or Transfusion Medicine staff are notified of RhD‐mismatched blood transfusions. Women with childbearing potential are evaluated by Obstetrics and Gynecology (ObGyn) to determine patients' childbearing desires and physical capabilities, as well as their ability to tolerate RhIG administration. Pathologists determine eligibility for therapy with RhIG: criteria include RhD negative females,

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rh-Hr Blood-Group SystemRho(D) Immune GlobulinRh IsoimmunizationBlood TransfusionHumansFemalePregnancyAdultClinical ProtocolsFetomaternal TransfusionMiddle Aged

Stichwörter der Autor:innen

RhD alloimmunizationRhD mismatchchildbearing‐age femalestransfusionwhole blood

Substanzen

Rh-Hr Blood-Group SystemRho(D) Immune GlobulinRho(D) antigen

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, UT Health San Antonio, San Antonio, Texas, USA.
  • Department of Surgery, UT Health San Antonio, San Antonio, Texas, USA.
  • Department of Obstetrics and Gynecology, UT Health San Antonio, San Antonio, Texas, USA.

ORCID-Profile: Kirea Mazzolini

Zitieren

APA

Alkhateb, R., Mazzolini, K., Prajapati, V. P., Harrison, C., Ireland, K. E., Jenkins, D., Daniels, J., & Greebon, L. (2025). How I do it: An institutional protocol for the management of RhD negative women who receive RhD positive blood. Transfusion. https://doi.org/10.1111/trf.18181

Vancouver

Alkhateb R, Mazzolini K, Prajapati VP, Harrison C, Ireland KE, Jenkins D, et al. How I do it: An institutional protocol for the management of RhD negative women who receive RhD positive blood. Transfusion. 2025. doi:10.1111/trf.18181

BibTeX
@article{Alkhateb2025,
  author = {Alkhateb, Rahaf and Mazzolini, Kirea and Prajapati, Vipulkumar Pravinbhai and Harrison, Chantal and Ireland, Kayla E and Jenkins, Donald and Daniels, John and Greebon, Leslie},
  title = {How I do it: An institutional protocol for the management of RhD negative women who receive RhD positive blood},
  journal = {Transfusion},
  year = {2025},
  doi = {10.1111/trf.18181}
}
Kostenlos starten →